CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ (298,000)	$ 756,000
Adjustments to reconcile net income (loss) to net cash:
Stock compensation expense	279,000	351,000
Foreign exchange loss (gain)	26,000	13,000
Depreciation and amortization	1,056,000	927,000
Deferred income taxes	205,000	(524,000)
Non Cash R & D Services	0	209,000
Other	34,000	(6,000)
Other changes in assets and liabilities:
Accounts receivable, net	(1,321,000)	(362,000)
Unbilled receivables	(1,168,000)	253,000
Contract assets	(61,000)	0
Inventories	(503,000)	(153,000)
Prepaid expenses and other assets	(55,000)	42,000
Accounts payable	203,000	(447,000)
Accrued expenses and other liabilities	(129,000)	55,000
Contract liabilities	(219,000)	(20,000)
Net cash from operating activities	(1,951,000)	1,094,000
Cash flows from investing activities:
Purchases of property, plant and equipment	(679,000)	(1,788,000)
Purchase of intangibles		(65,000)
Net cash from investing activities	(679,000)	(1,853,000)
Cash flows from financing activities:
Proceeds from issuance of common stock	14,000	13,000
Principal payments on capital leases	(29,000)	(72,000)
Proceeds from (payments of) line of credit, net	961,000	0
Proceeds from (payments of) equipment line of credit, net	484,000	281,000
Proceeds from (payments of) bank and subordinated debt, net	(584,000)	(329,000)
Net cash from financing activities	846,000	(107,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(24,000)	(38,000)
Net change in cash and cash equivalents	(1,808,000)	(904,000)
Cash and cash equivalents, beginning	2,327,000	2,415,000
Cash and cash equivalents, ending	519,000	1,511,000
Supplemental disclosures of cash flow information:
Cash paid (received) during the year for: Interest	132,000	109,000
Cash paid (received) during the year for: Tax payments (refunds)	(5,000)	7,000
Non cash activities:
Equipment Line of credit to term note conversion	484,000	0
Xcede stock surrender of Series A Preferred	18,000	0
Assets purchased under capital leases	$ 0	$ 12,000